Sepsis Diagnostics Market By Pathogen (Bacterial And Fungal), By Product (Instruments, Blood Culture Media, Assay Kits And Reagents), By Technology (Molecular Diagnostics, Microbiology, Immunoassay And Flow Cytometry), By Method (Conventional And Automated), By Usability (Laboratory And POC) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Sepsis Diagnostics Market By Pathogen (Bacterial And Fungal), By Product (Instruments, Blood Culture Media, Assay Kits And Reagents), By Technology (Molecular Diagnostics, Microbiology, Immunoassay And Flow Cytometry), By Method (Conventional And Automated), By Usability (Laboratory And POC) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 2943 | Pages: 180 | August 2017 | Region: Global


The Global Sepsis Diagnostics Market was worth USD 370 million in 2016 and estimated to be growing at a CAGR of 8.8%, to reach USD 564.1 million by 2021. The increasing prevalence of the disease and its fatal effects have stimulated its growth.

Sepsis can be defined as the body’s reaction to the fungal, bacterial, viral, or parasitic infection, which may further lead to systemic inflammatory reaction and organ dysfunction or organ failure. Sepsis is one of the most common causes of death in hospitalized patients. According to data revealed by the Centers for Disease Control and Prevention, sepsis affects around 800,000 people in the U.S. each year and it is the ninth leading cause of disease-related deaths in North America. Death can be as a result of hypotension, organ failure, high heart rate, and extreme body temperatures or due to a combination of these. It is more common in the elderly and infants.

The growth of Sepsis Diagnostics market is attributed to factors like rising prevalence of different antibiotic resistant bacterial strains, increasing geriatric population, growing number of surgical procedures, high incidence rates of hospital acquired infections and increasing number of product approvals. However factors like lack of standard protocols, lack of awareness and dearth or skilled staff are likely to hamper the growth of market.

The Global market for Sepsis Diagnostics is segmented based on Pathogen, Product, Technology, Method and Usability. Based on Pathogen – Bacterial and Fungal. Based on Product - Instruments, Blood Culture Media, Assay Kits and Reagents. Based on Technology - Molecular Diagnostics, Microbiology, Immunoassay and Flow Cytometry. Based on Method – Conventional and Automated. Based on Usability - Laboratory and Point-of-care testing. Based on Geographical analysis the market is separated into regions of North America, Asia-Pacific, Europe, Latin America and Middle East and Africa. North America is leading the market while Europe is at second place. Growing focus of stakeholders on research projects, drug discovery and diagnosis has helped North America dominate the market. Asia Pacific is expected to grow the fastest owing to number of factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players in this region. Bacterial Sepsis Diagnostics have accounted for major share among the pathogen segment. Molecular Diagnostics is expected to grow the fastest among the technology segment. Blood culture media is regarded as the standard treatment procedure and holds the major share among the products segment.

Some of the key players dominating this market include bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Pathogen                    

                                5.1.1 Introduction           

                                5.1.2 Bacterial Sepsis     

                                                5.1.2.1 Gram-Negative Bacterial Sepsis

                                                5.1.2.2 Gram-Positive Bacterial Sepsis

                                5.1.3 Fungal Sepsis         

                                5.1.4 Other Pathogen Infections              

                                5.1.5  Y-o-Y Growth Analysis, By Pathogen           

                                5.1.6  Market Attractiveness Analysis, By Pathogen         

                                5.1.7  Market Share Analysis, By Pathogen          

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Instruments           

                                5.2.3 Blood Culture Media           

                                5.2.4 Assay Kits & Reagents        

                                5.2.5 Software  

                                5.2.6 Y-o-Y Growth Analysis, By Product               

                                5.2.7 Market Attractiveness Analysis, By Product             

                                5.2.8 Market Share Analysis, By Product               

                5.3 Technology                 

                                5.3.1 Introduction           

                                5.3.2 Microbiology          

                                5.3.3 Molecular Diagnostics        

                                5.3.4 Immunoassays      

                                5.3.5 Flow Cytometry    

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8  Market Attractiveness Analysis, By Technology     

                                5.3.9  Market Share Analysis, By Technology       

                5.4 Method                       

                                5.4.1 Introduction           

                                5.4.2 Convential Diagnostics       

                                5.4.3 Automated Diagnostics     

                                5.4.4 Y-o-Y Growth Analysis, By Method               

                                5.4.5  Market Attractiveness Analysis, By Method            

                                5.4.6  Market Share Analysis, By Method             

                5.5 Usability                       

                                5.5.1 Introduction           

                                5.5.2 Laboratory Testing               

                                5.5.3 Point-of-Care Testing         

                                5.5.4 Y-o-Y Growth Analysis, By Usability              

                                5.5.5 Market Attractiveness Analysis, By Usability            

                                5.5.6 Market Share Analysis, By Usability              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Pathogen

                                                6.1.3.3 By Product

                                                6.1.3.4 By Technology

                                                6.1.3.5 By Method

                                                6.1.3.6 By Usability

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Pathogen

                                                6.1.4.3 By Product

                                                6.1.4.4 By Technology

                                                6.1.4.5 By Method

                                                6.1.4.6 By Usability

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Pathogen

                                                6.1.5.3 By Product

                                                6.1.5.4 By Technology

                                                6.1.5.5 By Method

                                                6.1.5.6 By Usability

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 bioMérieux SA                          

                                8.1.1 Overview 

                                8.1.2 Pathogen Analysis               

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 T2 Biosystem Inc                      

                8.3 Cepheid                       

                8.4 Thermo Fisher Scientific Inc.                               

                8.5 Nanosphere Inc                        

                8.6 Abbott Laboratories                               

                8.7 Roche Diagnostics Limited                    

                8.8 Becton, Dickinson and Company                       

                8.9 Bruker Corporation                 

                8.10 Beckman Coulter, Inc                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  2. Global Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  3. Global Bacterial Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  4. Global Fungal Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  5. Global Other Pathogen Infections Market By Region, From 2016-2021 ( USD Million )
  6. Global Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  7. Global Instruments Market By Region, From 2016-2021 ( USD Million )
  8. Global Blood Culture Media Market By Region, From 2016-2021 ( USD Million )
  9. Global Assay Kits and Reagents Market By Region, From 2016-2021 ( USD Million )
  10. Global Software Market By Region, From 2016-2021 ( USD Million )
  11. Global Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  12. Global Molecular Diagnostics Market By Region, From 2016-2021 ( USD Million )
  13. Global Microbiology Market By Region, From 2016-2021 ( USD Million )
  14. Global Immunoassay Market By Region, From 2016-2021 ( USD Million )
  15. Global Flow Cytometry Market By Region, From 2016-2021 ( USD Million )
  16. Global Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  17. Global Conventional Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  18. Global Automated Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  19. Global Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  20. Global Laboratory Testing Market By Region, From 2016-2021 ( USD Million )
  21. Global Point-of-Care Testing Market By Region, From 2016-2021 ( USD Million )
  22. North America Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  23. North America Bacterial Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  24. North America Fungal Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  25. North America Other Pathogen Infections Market By Region, From 2016-2021 ( USD Million )
  26. North America Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  27. North America Instruments Market By Region, From 2016-2021 ( USD Million )
  28. North America Blood Culture Media Market By Region, From 2016-2021 ( USD Million )
  29. North America Assay Kits and Reagents Market By Region, From 2016-2021 ( USD Million )
  30. North America Software Market By Region, From 2016-2021 ( USD Million )
  31. North America Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  32. North America Molecular Diagnostics Market By Region, From 2016-2021 ( USD Million )
  33. North America Microbiology Market By Region, From 2016-2021 ( USD Million )
  34. North America Immunoassay Market By Region, From 2016-2021 ( USD Million )
  35. North America Flow Cytometry Market By Region, From 2016-2021 ( USD Million )
  36. North America Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  37. North America Conventional Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  38. North America Automated Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  39. North America Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  40. North America Laboratory Testing Market By Region, From 2016-2021 ( USD Million )
  41. North America Point-of-Care Testing Market By Region, From 2016-2021 ( USD Million )
  42. United States Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  43. United States Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  44. United States Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  45. United States Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  46. United States Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  47. Canada Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  48. Canada Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  49. Canada Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  50. Canada Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  51. Canada Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  52. Europe Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  53. Europe Bacterial Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  54. Europe Fungal Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  55. Europe Other Pathogen Infections Market By Region, From 2016-2021 ( USD Million )
  56. Europe Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  57. Europe Instruments Market By Region, From 2016-2021 ( USD Million )
  58. Europe Blood Culture Media Market By Region, From 2016-2021 ( USD Million )
  59. Europe Assay Kits and Reagents Market By Region, From 2016-2021 ( USD Million )
  60. Europe Software Market By Region, From 2016-2021 ( USD Million )
  61. Europe Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  62. Europe Molecular Diagnostics Market By Region, From 2016-2021 ( USD Million )
  63. Europe Microbiology Market By Region, From 2016-2021 ( USD Million )
  64. Europe Immunoassay Market By Region, From 2016-2021 ( USD Million )
  65. Europe Flow Cytometry Market By Region, From 2016-2021 ( USD Million )
  66. Europe Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  67. Europe Conventional Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  68. Europe Automated Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  69. Europe Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  70. Europe Laboratory Testing Market By Region, From 2016-2021 ( USD Million )
  71. Europe Point-of-Care Testing Market By Region, From 2016-2021 ( USD Million )
  72. U.K. Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  73. U.K. Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  74. U.K. Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  75. U.K. Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  76. U.K. Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  77. Germany Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  78. Germany Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  79. Germany Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  80. Germany Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  81. Germany Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  82. France Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  83. France Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  84. France Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  85. France Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  86. France Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  87. Italy Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  88. Italy Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  89. Italy Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  90. Italy Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  91. Italy Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  92. Spain Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  93. Spain Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  94. Spain Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  95. Spain Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  96. Spain Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  97. Asia-Pacific Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  98. Asia-Pacific Bacterial Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  99. Asia-Pacific Fungal Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  100. Asia-Pacific Other Pathogen Infections Market By Region, From 2016-2021 ( USD Million )
  101. Asia-Pacific Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  102. Asia-Pacific Instruments Market By Region, From 2016-2021 ( USD Million )
  103. Asia-Pacific Blood Culture Media Market By Region, From 2016-2021 ( USD Million )
  104. Asia-Pacific Assay Kits and Reagents Market By Region, From 2016-2021 ( USD Million )
  105. Asia-Pacific Software Market By Region, From 2016-2021 ( USD Million )
  106. Asia-Pacific Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  107. Asia-Pacific Molecular Diagnostics Market By Region, From 2016-2021 ( USD Million )
  108. Asia-Pacific Microbiology Market By Region, From 2016-2021 ( USD Million )
  109. Asia-Pacific Immunoassay Market By Region, From 2016-2021 ( USD Million )
  110. Asia-Pacific Flow Cytometry Market By Region, From 2016-2021 ( USD Million )
  111. Asia-Pacific Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  112. Asia-Pacific Conventional Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  113. Asia-Pacific Automated Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  114. Asia-Pacific Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  115. Asia-Pacific Laboratory Testing Market By Region, From 2016-2021 ( USD Million )
  116. Asia-Pacific Point-of-Care Testing Market By Region, From 2016-2021 ( USD Million )
  117. Japan Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  118. Japan Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  119. Japan Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  120. Japan Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  121. Japan Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  122. China Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  123. China Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  124. China Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  125. China Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  126. China Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  127. India Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  128. India Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  129. India Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  130. India Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  131. India Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  132. Australia Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  133. Australia Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  134. Australia Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  135. Australia Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  136. Australia Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  137. South Korea Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  138. South Korea Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  139. South Korea Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  140. South Korea Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  141. South Korea Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  142. Latin America Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  143. Latin America Bacterial Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  144. Latin America Fungal Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  145. Latin America Other Pathogen Infections Market By Region, From 2016-2021 ( USD Million )
  146. Latin America Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  147. Latin America Instruments Market By Region, From 2016-2021 ( USD Million )
  148. Latin America Blood Culture Media Market By Region, From 2016-2021 ( USD Million )
  149. Latin America Assay Kits and Reagents Market By Region, From 2016-2021 ( USD Million )
  150. Latin America Software Market By Region, From 2016-2021 ( USD Million )
  151. Latin America Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  152. Latin America Molecular Diagnostics Market By Region, From 2016-2021 ( USD Million )
  153. Latin America Microbiology Market By Region, From 2016-2021 ( USD Million )
  154. Latin America Immunoassay Market By Region, From 2016-2021 ( USD Million )
  155. Latin America Flow Cytometry Market By Region, From 2016-2021 ( USD Million )
  156. Latin America Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  157. Latin America Conventional Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  158. Latin America Automated Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  159. Latin America Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  160. Latin America Laboratory Testing Market By Region, From 2016-2021 ( USD Million )
  161. Latin America Point-of-Care Testing Market By Region, From 2016-2021 ( USD Million )
  162. Brazil Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  163. Brazil Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  164. Brazil Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  165. Brazil Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  166. Brazil Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  167. Argentina Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  168. Argentina Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  169. Argentina Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  170. Argentina Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  171. Argentina Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  172. Mexico Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  173. Mexico Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  174. Mexico Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  175. Mexico Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  176. Mexico Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  177. Rest of Latin America Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  178. Rest of Latin America Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  179. Rest of Latin America Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  180. Rest of Latin America Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  181. Rest of Latin America Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  182. Middle East & Africa Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  183. Middle East & Africa Bacterial Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  184. Middle East & Africa Fungal Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  185. Middle East & Africa Other Pathogen Infections Market By Region, From 2016-2021 ( USD Million )
  186. Middle East & Africa Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  187. Middle East & Africa Instruments Market By Region, From 2016-2021 ( USD Million )
  188. Middle East & Africa Blood Culture Media Market By Region, From 2016-2021 ( USD Million )
  189. Middle East & Africa Assay Kits and Reagents Market By Region, From 2016-2021 ( USD Million )
  190. Middle East & Africa Software Market By Region, From 2016-2021 ( USD Million )
  191. Middle East & Africa Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  192. Middle East & Africa Molecular Diagnostics Market By Region, From 2016-2021 ( USD Million )
  193. Middle East & Africa Microbiology Market By Region, From 2016-2021 ( USD Million )
  194. Middle East & Africa Immunoassay Market By Region, From 2016-2021 ( USD Million )
  195. Middle East & Africa Flow Cytometry Market By Region, From 2016-2021 ( USD Million )
  196. Middle East & Africa Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  197. Middle East & Africa Conventional Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  198. Middle East & Africa Automated Sepsis Diagnostics Market By Region, From 2016-2021 ( USD Million )
  199. Middle East & Africa Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  200. Middle East & Africa Laboratory Testing Market By Region, From 2016-2021 ( USD Million )
  201. Middle East & Africa Point-of-Care Testing Market By Region, From 2016-2021 ( USD Million )
  202. Middle East Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  203. Middle East Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  204. Middle East Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  205. Middle East Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  206. Middle East Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
  207. Africa Sepsis Diagnostics Market By Pathogen, From 2016-2021 ( USD Million )
  208. Africa Sepsis Diagnostics Market By Products, From 2016-2021 ( USD Million )
  209. Africa Sepsis Diagnostics Market By Technology, From 2016-2021 ( USD Million )
  210. Africa Sepsis Diagnostics Market By Method, From 2016-2021 ( USD Million )
  211. Africa Sepsis Diagnostics Market By Usability, From 2016-2021 ( USD Million )
Middle East And Africa Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridizat...
Latin America Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End...
Asia Pacific Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End ...
Europe Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (...
North America Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End...
Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospita...
Middle East And Africa RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray...
Latin America RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RN...
Asia Pacific RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNA...
Europe RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNAi), By...
North America RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RN...
RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNAi), By Region...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.